IP Library Granted Patent US 9,327,118
Granted Patent B2
US 9,327,118 · App. 14/337,612 · Granted May 3, 2016

Non-invasive treatment of bronchial constriction

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,327,118
App. No.
14/337,612
Granted
May 3, 2016
Kind
B2
Abstract

Devices, systems and methods are disclosed for treating bronchial constriction related to asthma, anaphylaxis or chronic obstructive pulmonary disease. The treatment comprises transmitting impulses of energy non-invasively to selected nerve fibers that are responsible for smooth muscle dilation. The transmitted energy impulses, comprising magnetic and/or electrical, mechanical and/or acoustic, and optical and/or thermal energy, stimulate the selected nerve fibers.

Claims (31)

1. A method of treating a disease or a disorder in a patient, the method comprising:

positioning one or more energy transmitters within a container comprising an electrically conducting fluid such that the one or more energy transmitters is at least partially surrounded by and in contact with the electrically conductive fluid, wherein the container is coupled to a power source, wherein the container and the power source are housed in a housing, wherein the housing comprises a surface;

positioning the surface of the housing against an outer skin surface of a neck of a patient; and

applying sufficient energy to the one or more energy transmitters via the power source to generate one or more electrical impulses at or near a vagus nerve of the patient, wherein the one or more electrical impulses is sufficient to stimulate an activity of the vagus nerve to treat the disease or the disorder.

2. The method of claim 1 , wherein the one or more energy transmitters comprises a magnetic coil and the sufficient energy comprises a magnetic field.

3. The method of claim 2 wherein the electrically conductive fluid is an electrically conductive gel.

4. The method of claim 2 wherein the electrically conductive fluid contains ferromagnetic particles.

5. The method of claim 2 wherein the electrically conductive fluid comprises a magnetorheological fluid.

6. The method of claim 2 wherein the electrically conductive fluid is a combination of at least a magnetorheological fluid and a ferrofluid.

7. The method of claim 2 , wherein the magnetic coil comprises a toroid.

8. The method of claim 1 , wherein the one or more energy transmitters comprises an electrode and the sufficient energy comprises an electric current.

9. The method of claim 1 , wherein the one or more electrical impulses comprises a pulsed-on time from about 50 to about 500 microseconds.

10. The method of claim 1 , wherein the one or more electrical impulses is sufficient to stimulate an afferent fiber of the vagus nerve.

11. The method of claim 1 , wherein the disease or the disorder comprises bronchoconstriction.

12. The method of claim 1 , wherein the one or more electrical impulses comprises a frequency from about 1 to about 3000 Hz.

13. The method of claim 1 , wherein the one or more electrical impulses comprises a frequency from about 15 to about 50 Hz.

14. A device for treating a disease or a disorder of a patient, the device comprising:

a housing;

a power source housed within the housing;

a container housed within the housing, wherein the container comprises an interior and one or more energy transmitters positioned within the interior, wherein the container is coupled to the power source, wherein the interior is at least partially filled with an electrically conductive fluid, wherein the one or more energy transmitters is at least partially surrounded by and in contact with the electrically conductive fluid; and

wherein the power source supplies energy to the one or more energy transmitters and the energy is sufficient to generate one or more electrical impulses at a vagus nerve of the patient sufficient to treat the disease or the disorder.

15. The device of claim 14 , wherein the one or more energy transmitters comprises a magnetic coil and the energy comprises a magnetic field.

16. The device of claim 15 wherein the electrically conductive fluid contains ferromagnetic particles.

17. The device of claim 15 wherein the electrically conductive fluid comprises a magnetorheological fluid.

18. The device of claim 15 wherein the electrically conductive fluid is a combination of at least a magnetorheological fluid and a ferrofluid.

19. The device of claim 15 , wherein the magnetic coil comprises a toroid.

20. The device of claim 14 , wherein the one or more energy transmitters comprises an electrode and the energy comprises an electric current.

21. The device of claim 14 , wherein the one or more electrical impulses comprises a pulsed-on time from about 50 to about 500 microseconds.

22. The device of claim 14 , wherein the disease or the disorder comprises bronchoconstriction.

23. The device of claim 14 , wherein the one or more electrical impulses comprises a frequency from about 1 to about 3000 Hz.

24. The device of claim 14 , wherein the one or more electrical impulses comprises a frequency from about 15 to about 35 Hz.

Assignments (4)
SECURITY INTEREST Recorded Oct 16, 2024
From: NUVAIRA, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND 1, LP
Reel/Frame 069175/0918 →
RELEASE OF SECURITY INTEREST Recorded Jun 21, 2023
From: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
To: NUVAIRA, INC.
Reel/Frame 064017/0683 →
SECURITY INTEREST Recorded Dec 21, 2021
From: NUVAIRA, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND 1, LP
Reel/Frame 058561/0979 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2014
From: SIMON, BRUCE J.; ERRICO, JOSEPH P.; RAFFLE, JOHN T.; MENDEZ, STEVEN
To: ELECTROCORE, LLC
Reel/Frame 033541/0222 →